Rheumatoid arthritis and genetic variations in cytokine genes: a population-based study in Kashmir Valley

References

• Abbot SE, Kaul A, Stevens CR, Blake DR. (1992). Isolation and culture of synovial microvascular endothelial cells. Characterization and assessment of adhesion molecule expression. Arthritis Rheum, 35, 401–6
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. (2010). Rheumatoid arthritis classification criteria. Arthritis Rheumat, 62, 2569–81. DOI 10.1002/art.27584
   PubMed Web of Science ®Google Scholar
• Arend WP. (2002). The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev, 13, 323–40
   PubMed Web of Science ®Google Scholar
• Barton A, Worthington J. (2009). Genetic susceptibility to rheumatoid arthritis: An emerging picture. Arthritis Rheum, 61, 1441–6
   PubMed Web of Science ®Google Scholar
• Bresnihan B, Cobby M. (2003). Clinical and radiological effects of anakinra in patients with rheumatoid arthritis. Rheumatology (Oxford), 42, ii22–8. [PubMed: 12817092]
   PubMed Web of Science ®Google Scholar
• Buchs N, di Giovine FS, Silvestri T, et al. (2001). IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: Interaction with their plasma levels. Genes Immun, 2, 222--228
   PubMed Web of Science ®Google Scholar
• Chung SJ, Kwon YJ, Park MC, et al. (2011). The correlation between increased serum concentrations of interleukin-6 family cytokines and disease activity in rheumatoid arthritis patients. Yonsei Med J, 52, 113–20
   PubMed Web of Science ®Google Scholar
• Cox A, Camp NJ, Cannings C, et al. (1999). Combined sib-TDT and TDT provide evidence for linkage of the interleukin-1 gene cluster to erosive rheumatoid arthritis. Hum Mol Genet, 8, 1707--1713
   PubMed Web of Science ®Google Scholar
• Dayer JM. (2003). The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis. Rheumatology (Oxford), 42, ii3–10. [PubMed: 12817089]
   PubMedGoogle Scholar
• Deighton CM, Walker DJ, Griffiths ID, Roberts DF. (1989). The contribution of HLA to rheumatoid arthritis. Clin Genet, 36, 178–82
   PubMed Web of Science ®Google Scholar
• Dieudé P. (2009). Rheumatic diseases: Environment and genetics. Joint Bone Spine, 76, 602–7
   PubMed Web of Science ®Google Scholar
• Di Giovine FS, Takhsh E, Blakemore AI, Duff GW. (1992). Single base polymorphism at −511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet, 1, 450
   PubMedGoogle Scholar
• Fabris M, Quartuccio L, Lombardi S, et al. (2010). Study on the possible role of the −174G/C IL- 6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis. Reumatismo, 62, 253–8
   PubMedGoogle Scholar
• Fishman D, Faulds G, Jeffery R, et al. (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest, 102(7), 1369--76
   Google Scholar
• Feldmann M, Brennan FM, Maini RN. (1996). Role of cytokines in rheumatoid arthritis. Annu Rev Immunol, 14, 397–440
   PubMed Web of Science ®Google Scholar
• Firestein GS, Alvaro-Gracia JM, Maki R. (1990). Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol, 144, 3347
   PubMed Web of Science ®Google Scholar
• Fishman D, Faulds G, Jeffery R, et al. (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest, 102, 1369–76
   PubMed Web of Science ®Google Scholar
• FitzGerald O, Soden M, Yanni G, et al. (1991). Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis. Ann Rheum Dis, 50, 792–6
   PubMed Web of Science ®Google Scholar
• Fonseca JE, Santos MJ, Canha OH, Choy E. (2009). Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev, 8, 538–42
   PubMed Web of Science ®Google Scholar
• Guerne PA, Zuraw BL, Vaughan JH, et al. (1989). Synovium as a source of interleukin 6 in vitro: Contribution to local and systemic manifestations of arthritis. J Clin Invest, 83, 583--585
   Google Scholar
• Hall SK, Perregaux DG, Gabel CA, et al. (2004). Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum, 50, 1976–83
   PubMed Web of Science ®Google Scholar
• Horai R, Saijo S, Tanioka H, et al. (2000). Development of chronic inflammatory arthropathy resembeling rheumatoid arthritis in interleukin-1 receptor antagonist-deficient mice. J Exp Med, 191, 313–20
   PubMed Web of Science ®Google Scholar
• Iguchi T, Ziff M. (1986). Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation. J Clin Invest, 77, 355–61
   PubMed Web of Science ®Google Scholar
• Kishimoto T. (2005). Interleukin-6: From basic science to medicine – 40 years in immunology. Annu Rev Immunol, 23, 1–21
   PubMed Web of Science ®Google Scholar
• Lawrence JS. (1961). Prevalence of rheumatoid arthritis. Ann Rheum Dis, 20, 11–7
   PubMed Web of Science ®Google Scholar
• Lee YH, Bae SC, Choi SJ, et al. (2012). The association between interleukin-6 polymorphisms and rheumatoid arthritis: A meta-analysis. Inflamm Res, 61, 665–71
   PubMed Web of Science ®Google Scholar
• Lubbe S, Tikly M, van der Merwe L, et al. (2008). Interleukin-1 receptor antagonist gene polymorphisms are associated with disease severity in Black South Africans with rheumatoid arthritis. Joint Bone Spine, 75, 422–5
   PubMed Web of Science ®Google Scholar
• Malaviya AN, Kapoor S, Singh RR, et al. (1993). Prevalence of rheumatoid arthritis in the adult Indian population. Rheumatol Int, 13, 131–4
   PubMed Web of Science ®Google Scholar
• Marinou I, Healy J, Mewar D, et al. (2007). Association of interleukin-6 and interleukin-10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status. Arthritis Rheum, 56, 2549–56
   PubMed Web of Science ®Google Scholar
• Pawlik A, Wrzesniewska J, Florczak M, et al. (2005). IL-6 promoter polymorphism in patients with rheumatoid arthritis. Scand J Rheumatol, 34, 109–13
   PubMed Web of Science ®Google Scholar
• Pincus T. (1995). Long-term outcomes in rheumatoid arthritis. Br J Rheumatol, 34, 59–73
   PubMedGoogle Scholar
• Pocoit F, Molvig J, Wogensel L, et al. (1992). A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest, 22, 396–402
   Google Scholar
• Postlethwaite AE, Lachman LB, Kang AH. (1984). Induction of fibroblast proliferation by interleukin-1 derived from human monocytic leukemia cells. Arthritis Rheum, 27, 995
   PubMed Web of Science ®Google Scholar
• Sawada T, Hirohata S, Inoue T, Ito K. (1991). Correlation between rheumatoid factor and IL-6 activity in synovial fluids from patients with rheumatoid arthritis. Clin Exp Rheumatol, 9, 363–8
   Google Scholar
• van de Loo FA, Joosten LA, van Lent PL, et al. (1995). Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum, 38, 164–72
   PubMed Web of Science ®Google Scholar
• Wilson AG, Symons JA, McDowell TL, et al. (1997). Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA, 94, 3195–9
   PubMed Web of Science ®Google Scholar
• Zhang X, Llamado L, Pillay I, et al. (2002). Interleukin-1 gene polymorphism disease activity and bone mineral metabolism in rheumatoid arthritis. Chin Med J (Engl.), 115, 46–9
   PubMedGoogle Scholar